COVID-19 vaccination

training for health workers

Module 1:

Introduction to COVID-19
vaccination training

© WHO/Blink Media – Giliane Soupe

 |2

COVID-19 vaccinator training

o The objective of this training is to provide

key information on COVID-19 vaccination
to health workers/vaccinators.
o The training is based on information
available as of December 2020.*
o Information on COVID-19 vaccine specific
characteristics will be presented in
“vaccine explainers” as information
*Given the information about becomes available.
vaccines may change rapidly,
please check the WHO webpage
for the most up-to-date advice.
Contents of this training package |3

This training has 6 modules consisting of video lectures and downloadable slide sets.
• Module 1: Introduction to COVID-19 vaccination training
• Module 2: Storage, handling, delivery, and waste management of COVID-19 vaccines
• Module 3: Organizing COVID-19 vaccination sessions
• Module 4: AEFI monitoring for COVID-19 vaccination
• Module 5: Recording and monitoring COVID-19 vaccination
• Module 6: Communication with the community about COVID-19 vaccination

Within the training package, information that is new and/or different for COVID-19
vaccination is marked with an icon . Resources currently in development are
marked with an icon .
 |4
o Coronaviruses (CoV) are a large family of viruses
which cause a wide range of disease such as the
What are common cold, Middle East Respiratory Syndrome

Coronaviruses, (MERS) and Severe Acute Respiratory Syndrome

SARS-CoV-2 and
COVID-19?
To learn about COVID-19,
please refer to OpenWHO
COVID-19 channel:
https://openwho.org/channels/covid-19
(SARS).
o SARS-CoV-2 is a new strain of coronavirus.
o The disease caused by SARS-CoV-2 infection is called
Coronavirus disease (COVID-19).
o The symptoms of COVID-19 may vary. Common
symptoms include: mild fever, cough, fatigue, shortness
of breath, and myalgias (muscle aches).
o Anyone can become sick with COVID-19, regardless of
age and health status. People above the age of 60 and
those with underlying medical conditions are more at
risk.
o Complications of COVID-19 include severe disease
and may lead to death.
o The COVID-19 vaccine will be important for
protection from COVID-19.
 |5

o Please refer to your national/sub-national guidance

COVID-19 and target group recommendations.

vaccination • These recommendations are developed by the

National Immunization Technical Advisory Group
(NITAG) from global guidance developed by the
WHO’s Strategic Advisory Group of Experts on
Immunization (SAGE).
o Initial supply of COVID-19 vaccine will be limited.
• In the context of limited supply of COVID-19
vaccine, vaccination alone will not be sufficient to
prevent community level transmission.
• Public health and social measures (i.e. masks
and social distancing) should continue to be used.
o Before, during, and after vaccination, it is important
to continue following standard precautions for
infection prevention and control.
 |6

1. This training package is intended to provide

Summary of health workers with an overview of what is
key messages new or different for COVID-19 vaccination.
2. The COVID-19 vaccine will be important for
protection from COVID-19.
3. Ensure that you are following the national
and/or sub-national guidance and
recommendations.